Trials / Conditions / Overactive Bladder Syndrome

Overactive Bladder Syndrome

109 registered clinical trials studyying Overactive Bladder Syndrome — 19 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Defining the Safety and Efficacy of POSterIor Tibial NeRve StimulatiON in Children NCT06769854	Chi Dang Hornik	Phase 4
Recruiting	Yoga for Treatment of Overactive Bladder in Pediatric Patients NCT05895045	Duke University	N/A
Enrolling By Invitation	Moving Beyond p-Values: MCID for OAB-V8 8 and ICIQ-SF in Patients With OAB NCT07171424	Artvin Coruh University	N/A
Recruiting	Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladd NCT07416968	Mansoura University	Phase 4
Recruiting	Home-Based Transcutaneous Remotely Monitored Posterior Tibial Neuromodulation NCT07081412	Ege University	N/A
Completed	Prevalence And Risk Factors of Overactive Bladder Syndrome Among Egyptian Medical Students, and Their Impact O NCT07044778	Zagazig University	—
Recruiting	Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial NCT07184307	Benha University	N/A
Recruiting	Oral Lactobacillus Supplementation as Treatment for Overactive Bladder Syndrome: A Randomised Controlled Trial NCT06546189	Medical University of Vienna	N/A
Withdrawn	Role of Combination Therapy in Women With Refractory Overactive Bladder NCT06438861	University of Alabama at Birmingham	N/A
Not Yet Recruiting	Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Inject NCT06695585	University of Louisville	Phase 4
Recruiting	Improving Overactive Bladder Treatment Access and Adherence NCT06094543	Stanford University	N/A
Not Yet Recruiting	Transcutaneous Tibial Nerve Stimulation for Overactive Bladder Syndrome and Associated Gait Changes in Post-me NCT06617676	Louisiana State University Health Sciences Center Shreveport	N/A
Enrolling By Invitation	Overactive Bladder Syndrome and Hypopressive Exercise NCT06780657	Pamukkale University	N/A
Completed	RCT on Multimodal Self-treatment for Women With Incontinence Using a Digital Health Application NCT06389838	Kranus Health GmbH	N/A
Active Not Recruiting	Cyclic Versus Continuous Sacral Neuromodulation for LUTS NCT06170450	University Hospitals Cleveland Medical Center	N/A
Completed	Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women NCT06508944	Mahidol University	Phase 4
Enrolling By Invitation	Migraine Medication Effects on Urinary Symptoms NCT06212661	The Cleveland Clinic	—
Recruiting	Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome NCT06351683	Iman Al-Naggar, PhD	Phase 2
Recruiting	Impact of TTNS on Bladder Symptoms Among People With MS, A RCT NCT06341673	Hawra Al-Dandan	N/A
Completed	rTMS in Overactive Bladder NCT06198439	The Methodist Hospital Research Institute	N/A
Completed	Effect of TTNS and PNS on Neurogenic Overactive Bladder Symptoms in Female Patients With Multiple Sclerosis. NCT06143397	Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization	N/A
Enrolling By Invitation	Transvaginal Detrusor Nerve Radiofrequency Ablation for Treatment of Overactive Bladder NCT06283498	InMode MD Ltd.	N/A
Completed	Real-life Clinical Experience With Ialuadapter Study NCT06540248	Radboud University Medical Center	—
Unknown	Effect of Acupuncture Augmented With Pelvic Floor Exercises on Overactive Bladder NCT06088394	Cairo University	N/A
Active Not Recruiting	Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder NCT05977634	Ege University	N/A
Unknown	Telerehabilitation for Overactive Bladder Syndrome in Obese Women NCT06045728	Cairo University	N/A
Recruiting	Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms NCT05878951	Northwestern University	Phase 2 / Phase 3
Unknown	RF in the Treatment OAB in UUI- a Prospective Randomized Placebo Controlled Study NCT06080217	Ginekologija Dr. Franić, D.O.O.	N/A
Completed	Mobile Application and Bladder Training NCT05792956	Marmara University	N/A
Unknown	Xeomin vs Botox for Treatment of Overactive Bladder Syndrome NCT06034288	Walter Reed National Military Medical Center	Phase 2
Completed	Comparison of the Transcutaneous Tibial Nerve Stimulation and Drug Treatment' Effects in Women With Overactive NCT06024005	Ege University	N/A
Completed	Comparing Treatments for Refractory Overactive Bladder: Bladder Denervation vs Botulinum Toxin Injections NCT06796855	Bagcilar Training and Research Hospital	Phase 4
Completed	Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection NCT05719285	The Cleveland Clinic	Phase 4
Unknown	Developing a Simple Test to Diagnose Overactive Bladder NCT05572918	Teesside University	—
Recruiting	Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome NCT05221021	Walter Reed National Military Medical Center	Phase 4
Terminated	Cycling Study With the Axonics System NCT05543382	Axonics, Inc.	—
Terminated	INvestigation of TENS Efficacy Versus Posterior Tibial Nerve Stimulation for Overactive Bladder NCT05309993	University of New Mexico	N/A
Completed	Study of V117957 in Overactive Bladder Syndrome NCT06024642	Imbrium Therapeutics	Phase 1
Completed	Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial NCT05308979	University of California, Irvine	Phase 4
Unknown	Virtual Bladder Training for Overactive Bladder Syndrome in Women. Which Symptom Responds Better? NCT05493748	Hospital Italiano de Buenos Aires	N/A
Completed	Darifenacin x Parasacral Transcutaneous Electric Nerve Stimulation for OAB in Patients Infected With Human T-L NCT06616675	Hospital Universitário Professor Edgard Santos	Phase 4
Unknown	Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bl NCT05157295	Augusta University	Phase 4
Recruiting	BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder NCT04873037	Corewell Health East	N/A
Unknown	Sequencing and Combination of Mirabegron and TTNS in Overactive Bladder Syndrome: a Multicenter, Randomized, O NCT05188742	Taipei Veterans General Hospital, Taiwan	Phase 4
Recruiting	Oxybutynin for Post-surgical Bladder Pain and Urgency NCT03952299	University of California, Davis	Phase 3
Unknown	Using Oral Valacyclovir to Treat Patients With Refractory IC/BPS NCT05094414	Buddhist Tzu Chi General Hospital	Phase 1
Unknown	Predictors Affecting Long-term Use of Solifenacin or Mirabegron in Women With Overactive Bladder Syndrome NCT05040984	Far Eastern Memorial Hospital	—
Unknown	Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder NCT04909255	China Medical University Hospital	Phase 4
Unknown	Effect of beta3-adrenoceptor Agonist on Patients With Overactive Bladder and as a Urinary Biomarker NCT04693897	Chang Gung Memorial Hospital	—
Unknown	Comparison and Evaluation of USSQ, OABSS, and the Drainage/Anti-reflux Effect Between Three Kinds of Ureteral NCT04858750	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine	N/A
Completed	BE Technologies Mobile Uroflowmetry Validation Study NCT04599283	BE Technologies Inc	N/A
Completed	Minimizing Pain During Office Intradetrussor Botox Injection NCT04270526	Boston Urogynecology Associates	Phase 4
Completed	Tolterodine Relieves Overactive Bladder Symptoms in Women With Moderate-to-severe Obstructive Sleep Apnea Synd NCT05250245	Yuzuncu Yil University	Phase 4
Completed	Overactive Bladder Syndrome NCT05151081	Hisar Intercontinental Hospital	—
Completed	Comparison of Different Treatments for Overactive Bladder Syndrome NCT04197466	Ankara Yildirim Beyazıt University	N/A
Completed	Extracorporeal Magnetic Innervation in Combination With Mirabegron in the Treatment of Overactive Bladder NCT06123364	Serdinsek Tamara	N/A
Unknown	Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus Solifenacin NCT04023253	Far Eastern Memorial Hospital	Phase 3
Unknown	Efficacy of Transcutaneous Versus Percutaneous Posterior Tibial Nerve Stimulation in the Overactive Bladder. NCT04483817	Fisiocore LC,SL	N/A
Withdrawn	Impact of Beta-3 Agonist on Psychological Distress and Blood Flow of the Bladder in Women With Overactive Blad NCT03695822	Far Eastern Memorial Hospital	Phase 4
Unknown	Effects of Kinesio Taping Application in Women With Overactive Bladder NCT03817203	Ataturk Training and Research Hospital	N/A
Terminated	TTNS Versus Sham Therapy for Children With iOAB (TaPaS Part I) NCT04256876	University Hospital, Ghent	N/A
Unknown	Oral vs Intravesical Analgesia for Office Bladder Botox Injections NCT03755089	Women and Infants Hospital of Rhode Island	Phase 4
Completed	Treatment of the Overactive Bladder Syndrome: A Delphi Study NCT04300400	University Hospital, Ghent	—
Unknown	Use of Repris Needle in Bladder Injection NCT04982120	Uro-1 Medical	N/A
Unknown	Overactive Bladder Syndrome: Incobotulinumtoxin Versus Onabotulinumtoxin NCT03758235	University Of Perugia	Phase 3
Terminated	OnabotulinumtoxinA Bladder Injection Study NCT03523091	Corewell Health East	Phase 4
Unknown	Experience Sampling Method in OAB Patients NCT03435991	Maastricht University Medical Center	—
Unknown	Comparison of Solifenacin and Mirabegron in Treatment of Overactive Bladder Symptoms in Men After TURP NCT03632772	Buddhist Tzu Chi General Hospital	Phase 2
Completed	Effect of Ureteral Stents Length and Location on Related Symptom NCT05069376	Taipei Medical University Shuang Ho Hospital	N/A
Terminated	Condensed Percutaneous Tibial Nerve Stimulation (PTNS) Protocol NCT03559946	Stony Brook University	N/A
Completed	Herbal Patch for Overactive Bladder NCT03532789	En Chu Kong Hospital	Phase 2 / Phase 3
Terminated	Effectiveness of Bilateral PTNS Compared to Unilateral PTNS for the Treatment of Overactive Bladder/Urge Incon NCT03535857	Gnankang Sarah Napoe	N/A
Unknown	Efficacy of Different Electrical Stimulation Placement in Patients With Overactive Bladder Syndrome NCT03516435	Chung Shan Medical University	N/A
Completed	OptiLUTS Part C: the Development of a Symptom Assessment Tool in Sacral Neuromodulation. NCT05313984	University Hospital, Ghent	—
Unknown	Efficacy of Lower Limb Exercises on Overactive Bladder Symptoms in Patients With Multiple Sclerosis NCT03322748	IRCCS San Raffaele	N/A
Unknown	Effects of Bladder Training and Pelvic Floor Muscle Training on the Symptomatology of Overactive Bladder Syndr NCT03331081	Federal University of São Paulo	N/A
Unknown	Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime Dosing NCT03251300	Far Eastern Memorial Hospital	Phase 4
Unknown	Urodynamics and Clinical Factors That Are Associated With Bladder Over-sensitivity NCT03486639	Assaf-Harofeh Medical Center	—
Completed	Physiotherapy in Overactive Bladder: Electrical Stimulation Treatment NCT03250650	University of Sao Paulo General Hospital	N/A
Completed	Central Obesity in Cases of OAB NCT03750604	Mansoura University	N/A
Completed	Effectiveness of a Structured Intervention to Optimize the Use of Mirabegron NCT03536494	Catalan Institute of Health	N/A
Completed	Overactive Bladder in Elderly Patients- An Early Warning of Coronary Artery Disease NCT02854813	Ankara Training and Research Hospital	—
Unknown	Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan NCT03044912	Buddhist Tzu Chi General Hospital	Phase 3
Completed	Comparisons of the Effects of Solifenacin Versus Mirabegron on Autonomic System, Arterial Stiffness and Psycho NCT02540707	National Taiwan University Hospital	Phase 4
Completed	Trigonal vs Non Trigonal Botox Injection in OAB. NCT03533062	Mansoura University	N/A
Completed	Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan NCT03059134	Buddhist Tzu Chi General Hospital	Phase 3
Completed	Correlations of 3D Urethral and Paraurethral Sonographic Findings With Urodynamic Studies, Lower Urinary Tract NCT01884753	Far Eastern Memorial Hospital	—
Completed	Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder Syndrome NCT01912885	University of Sao Paulo General Hospital	N/A
Unknown	Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients NCT01876186	National Taiwan University Hospital	Phase 4
Completed	Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Night NCT01819168	Far Eastern Memorial Hospital	—
Unknown	Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive B NCT01627145	National Taiwan University Hospital	N/A
Completed	Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndro NCT02024945	Takeda	—
Completed	Intravesical Injection of Botox for Treating Therapy Refractory Overactive Bladder in Females NCT01042119	University of Zurich	—
Completed	Basic Sensations Coming From the Bladder NCT01114412	Maastricht University Medical Center	—
Withdrawn	Overactive Bladder (OAB) Drink Advice Study NCT00982241	Radboud University Medical Center	N/A
Unknown	The Effect of Position on Urge Sensation in Volunteers and in Patients With Overactive Bladder Syndrome NCT00821314	Maastricht University Medical Center	—
Completed	Trial of Maintenance Therapy With Posterior Tibial Nerve Stimulation for Overactive Bladder NCT00912314	University of California, San Diego	N/A
Unknown	Cystoscopy Plus Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impa NCT00839969	Medway NHS Foundation Trust	N/A
Completed	Colonization of the Female Urethra With Mycoplasma Hominis, Ureaplasma Urealyticum, Chlamydia Trachomatis, or NCT01559623	University of Zurich	—
Completed	Effect of Pulse Rate Changes on Clinical Outcome NCT01164280	Maastricht University Medical Center	N/A
Unknown	Non-Micturation Bladder Activity in Relation to Self-Consciousness During Filling Phase and Sensation Measurem NCT00628615	Maastricht University Medical Center	—
Completed	Fesoterodine "add-on" Male Overactive Bladder Study NCT00546637	Pfizer	Phase 3
Completed	Validation of a Real-time Urodynamic Measure of Urinary Urgency NCT00909428	Loyola University	Phase 4
Terminated	Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity NCT00335660	Avera Pharmaceuticals	Phase 2
Completed	Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the NCT00220402	Pfizer	Phase 3
Completed	Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the NCT00220376	Pfizer	Phase 3
Completed	A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overacti NCT00171145	Novartis	Phase 3
Completed	A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome NCT00220363	Pfizer	Phase 3
Completed	A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder NCT00170755	Novartis	Phase 3